Maternal influenza vaccination during pregnancy and risk of ASD in the offspring

BackgroundVaccination has been proposed as a potential risk factor for autism spectrum disorder (ASD), contributing to public hesitancy and mistrust toward immunization. Influenza vaccination during pregnancy is considered safe and effective in preventing serious maternal complications and adverse birth outcomes associated with influenza infection. However, limited research exists regarding the long-term impact of maternal influenza vaccination on offspring neurodevelopment. MethodsWe conducted a retrospective cohort study of all singleton live births among members of Clalit Health Services (CHS), Israels largest healthcare provider, between January 2016 and December 2020, with follow-up through May 2024. Offspring with developmental disorders of known genetic etiology were excluded. Maternal influenza vaccination during pregnancy (exposure) and offspring ASD diagnosis (outcome) were identified via CHS electronic medical records. The association between exposure and outcome was assessed using Cox proportional hazards models, adjusting for sociodemographic, maternal, and gestational covariates. ResultsOf 153,321 children included in the analysis, 39,361 (25.7%) were exposed to maternal influenza vaccination during pregnancy. A modestly increased risk of ASD was observed in the crude analysis among offspring of mothers who received influenza vaccination during pregnancy compared to those who did not (HR = 1.22, 95% CI: 1.14-1.31). However, this association was no longer evident after adjustment for sociodemographic and clinical covariates (aHR = 0.97, 95% CI: 0.91-1.05). ConclusionsMaternal influenza vaccination during pregnancy was not associated with an increased risk of ASD in offspring. These results support the long-term safety of maternal influenza vaccination as a preventive healthcare measure.